Care Access - Hoboken — Hoboken, New Jersey

Care Access - Hoboken is a clinical research site located in Hoboken, New Jersey, United States 07030.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Care Access - Hoboken has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Alzheimer's Disease, Atopic Hand and Foot Dermatitis, Psoriasis.

Sponsors: Eli Lilly and Company, Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access - Hoboken?

Care Access - Hoboken has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access - Hoboken conducted?

Care Access - Hoboken has 5 clinical trials on record, with 5 currently active. Their work covers Alzheimer's Disease, Atopic Hand and Foot Dermatitis, Psoriasis.

Is Care Access - Hoboken accredited by Crixeo Health?

Care Access - Hoboken has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access - Hoboken?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.